Buy, Sell or Hold: Symbiotic (SYM-Q)

Home

Daily Stock Opinions and Ratings

Symbiotic (SYM-Q)

NASDAQ:SYM

24.04

0.10 (0.42%) 1d

Nervous markets await Nvidia

Investor Insights

This summary was created by AI, based on 1 opinions in the last 12 months.

Symbiotic (SYM-Q) appears to be struggling significantly, particularly in its supply chain management sector, as highlighted by an expert review. There are notable concerns regarding the functionality of their high-powered robotic solutions, which are reportedly failing to deliver on promises. These shortcomings have led to advisories to avoid investing in the company, especially given the recent sell-off of its stock. Overall, there is a cautious tone among the experts, emphasizing that potential investors should proceed with extreme caution or look for better opportunities elsewhere. The negative sentiment surrounding Symbiotic reflects broader concerns about its operational capabilities and market readiness.

Consensus

Avoid

Valuation

Overvalued

Similar

Ceres, CERE

DON'T BUY

Don't touch supply chain management. Their high-powered robot hasn't been able to work. Avoid this, despite its sell-off.

DON'T BUY

A money-losing SPAC so he can't recommend it.

Showing 1 to 2 of 2 entries

Symbiotic(SYM-Q) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 1

Stockchase rating for Symbiotic is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Symbiotic(SYM-Q) Frequently Asked Questions

What is Symbiotic stock symbol?

Symbiotic is a American stock, trading under the symbol SYM-Q on the NASDAQ (SYM). It is usually referred to as NASDAQ:SYM or SYM-Q

Is Symbiotic a buy or a sell?

In the last year, 1 stock analyst published opinions about SYM-Q. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Symbiotic.

Is Symbiotic a good investment or a top pick?

Symbiotic was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Symbiotic.

Why is Symbiotic stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Symbiotic worth watching?

In the last year, there was no coverage of Symbiotic published on Stockchase.

What is Symbiotic stock price?

On 2025-05-09, Symbiotic (SYM-Q) stock closed at a price of $24.04.

Most Recent Experts

Michael Hakes - CFA, MBA

Murray Wealth Group

Daniel Straus

National Bank Financial

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.